Hutch News

Hutch News

Stories tagged 'testosterone'

What's new in prostate cancer: 5 takeaways

‘Many reasons for optimism’ says expert at annual community symposium

May 1, 2018 | by Susan Keown / Fred Hutch News Service

What's new in prostate cancer in 2018? The latest in prostate cancer treatment, screening, survivorship and more.

View story >


‘Bipolar’ therapy: Treating advanced prostate cancer with high-dose testosterone

Men with a certain type of aggressive prostate cancer may benefit from therapy that cycles hormones through high peaks and low valleys, small study finds

Jan. 7, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service

A new study from researchers at Johns Hopkins Hospital and Fred Hutchinson Cancer Research Center shows that a certain type of prostate cancer, after months or years of testosterone deprivation, can develop a lethal sensitivity to testosterone in a new treatment approach – “bipolar androgen therapy” – which combines high-dose testosterone with androgen-blocking therapy.

View story >


Intermittent hormone therapy for prostate cancer inferior to continuous therapy

Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival

June 4, 2012

Many men with metastatic, hormone-sensitive prostate cancer live longer on continuous androgen-deprivation therapy (also known as hormone therapy) than on intermittent therapy, according to a 17-year study led by SWOG (formerly Southwest Oncology Group), a cancer research cooperative group.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.